Characterization of the Intronic Splicing Silencers Flanking FGFR2 Exon IIIb
Open Access
- 1 April 2005
- journal article
- Published by Elsevier BV
- Vol. 280 (14), 14017-14027
- https://doi.org/10.1074/jbc.m414492200
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC‐3 cellsThe Prostate, 2004
- Requirement for fibroblast growth factor 10 or fibroblast growth factor receptor 2-IIIb signaling for cecal development in mouseDevelopmental Biology, 2003
- A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypesProceedings of the National Academy of Sciences of the United States of America, 2001
- Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndromeProceedings of the National Academy of Sciences, 2000
- De Novo Alu-Element Insertions in FGFR2 Identify a Distinct Pathological Basis for Apert SyndromeAmerican Journal of Human Genetics, 1999
- Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancerOncogene, 1997
- The Heparan Sulfate–Fibroblast Growth Factor Family: Diversity of Structure and FunctionProgress in Nucleic Acid Research and Molecular Biology, 1997
- Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy.Molecular and Cellular Biology, 1993
- Developmental Localization of the Splicing Alternatives of Fibroblast Growth Factor Receptor-2 (FGFR2)Developmental Biology, 1993
- Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.Proceedings of the National Academy of Sciences of the United States of America, 1992